当前位置:首页 - 行情中心 - 特一药业(002728) - 财务分析 - 利润表

特一药业

(002728)

  

流通市值:39.93亿  总市值:58.87亿
流通股本:2.47亿   总股本:3.65亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入1,067,212,110.88745,292,491.04538,380,647.61304,157,421.18
营业收入1,067,212,110.88745,292,491.04538,380,647.61304,157,421.18
二、营业总成本768,831,028.58530,069,204.22362,936,735.58180,960,104.9
营业成本467,988,066.72315,306,256.04222,051,486.34113,060,720.61
税金及附加12,280,710.817,780,366.775,628,656.343,281,119.59
销售费用174,358,859.57121,717,894.7880,615,456.4435,532,652.02
管理费用66,314,371.0247,175,974.8330,679,752.1316,364,068.33
研发费用43,064,055.632,470,860.5219,876,916.1810,182,147.51
财务费用4,824,964.865,617,851.284,084,468.152,539,396.84
其中:利息费用16,364,684.5814,031,419.689,550,830.954,020,174.86
其中:利息收入11,981,511.898,735,787.555,703,182.671,512,624.22
加:投资收益360,805.72270,082.2--
资产处置收益122,084.64120,628.33120,355.87-
资产减值损失(新)-13,162,491.94---
信用减值损失(新)-35,011.731,460,973.871,714,330.942,799,592.87
其他收益7,604,888.662,778,711.781,873,225.291,047,015.55
营业利润平衡项目0000
四、营业利润293,271,357.65219,853,683179,151,824.13127,043,924.7
加:营业外收入106,802.127,334.657,038.246,235.43
减:营业外支出384,245.99158,523.2178,523.2125,729.16
利润总额平衡项目0000
五、利润总额292,993,913.78219,702,494.44179,080,339.16127,024,430.97
减:所得税费用39,818,124.1631,220,244.6226,955,227.6921,553,510.03
六、净利润253,175,789.62188,482,249.82152,125,111.47105,470,920.94
持续经营净利润253,175,789.62188,482,249.82152,125,111.47105,470,920.94
归属于母公司股东的净利润253,175,789.62188,482,249.82152,125,111.47105,470,920.94
(一)基本每股收益0.770.590.470.46
(二)稀释每股收益0.770.570.460.44
九、综合收益总额253,175,789.62188,482,249.82152,125,111.47105,470,920.94
归属于母公司股东的综合收益总额253,175,789.62188,482,249.82152,125,111.47105,470,920.94
公告日期2024-03-082023-10-242023-08-292023-04-26
审计意见(境内)标准无保留意见
TOP↑